Cyclobenzaprine (Flexeril) is NOT recommended for menstrual cramping
Cyclobenzaprine should not be used for menstrual cramping—there is no evidence supporting its efficacy for this indication, and it is only FDA-approved for acute musculoskeletal spasm, not gynecologic pain. 1
Why Cyclobenzaprine is Inappropriate for Dysmenorrhea
Cyclobenzaprine is a centrally-acting skeletal muscle relaxant that works by reducing tonic somatic motor activity at the brainstem level 1. The pathophysiology of menstrual cramping involves prostaglandin-mediated uterine smooth muscle contraction and vasoconstriction 2—a completely different mechanism that cyclobenzaprine does not address. The drug acts on skeletal muscle spasm, not uterine smooth muscle cramping.
The FDA label explicitly states cyclobenzaprine is indicated only for "relief of muscle spasm associated with acute, painful musculoskeletal conditions" and recommends use for no longer than 2-3 weeks 1. There are no studies evaluating cyclobenzaprine for dysmenorrhea in any of the available evidence.
Evidence-Based First-Line Treatment for Menstrual Cramping
NSAIDs are the established first-line pharmacologic treatment for primary dysmenorrhea 3, 4, 2. They work by inhibiting cyclooxygenase enzymes and blocking prostaglandin formation—directly targeting the underlying cause of menstrual pain. Multiple studies demonstrate NSAIDs significantly reduce menstrual blood loss and pain compared to placebo 5.
Combined oral contraceptives (OCPs) are equally effective as first-line therapy 3, 6. OCPs reduce pain with a moderate effect size (SMD -0.58) and increase the likelihood of pain improvement 1.65-fold compared to placebo 6. Women using OCPs have a 37-60% chance of pain improvement versus 28% with placebo.
Treatment Algorithm for Menstrual Cramping
Start with NSAIDs: Ibuprofen 400-800mg every 6-8 hours or naproxen 500mg twice daily, taken during days of bleeding (typically 5-7 days) 5, 3
Add or switch to hormonal contraception if NSAIDs alone are insufficient:
Combination therapy: NSAIDs plus hormonal contraception can be used together for refractory cases 2
Non-pharmacologic adjuncts: Heat therapy and physical exercise have strong supporting evidence 2
Critical Safety Concerns with Cyclobenzaprine
Beyond lack of efficacy for dysmenorrhea, cyclobenzaprine carries significant risks:
- Sedation is extremely common: Over 30% of patients experience drowsiness, likely due to potent off-target antagonism of central histamine H1 receptors 7
- Anticholinergic effects: Confusion, hallucinations, urinary retention, dry mouth, constipation 8
- Pregnancy concerns: One case report suggests maternal cyclobenzaprine use may cause in-utero ductal closure and persistent pulmonary hypertension in neonates 9
- Drug interactions: Risk of serotonin syndrome with MAO inhibitors; potentiates norepinephrine 8
The typical dosing is 5-10mg three times daily for immediate-release or 15-30mg once daily for extended-release 1, 10, but again, this is irrelevant for menstrual cramping as the drug should not be used for this indication.
Common Pitfall to Avoid
Do not prescribe muscle relaxants like cyclobenzaprine for menstrual pain simply because patients describe "cramping." Uterine cramping is fundamentally different from skeletal muscle spasm. The term "cramp" refers to prostaglandin-mediated smooth muscle contraction in the uterus, not skeletal muscle pathology. Using cyclobenzaprine exposes patients to sedation and anticholinergic side effects without addressing the underlying prostaglandin-driven pain mechanism.